home / stock / hlukf / hlukf quote
Last: | $24.625 |
---|---|
Change Percent: | 6.88% |
Open: | $23.98 |
Close: | $24.625 |
High: | $24.625 |
Low: | $23.94 |
Volume: | 232 |
Last Trade Date Time: | 06/08/2022 04:52:15 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$24.625 | $23.98 | $24.625 | $24.625 | $23.94 | 232 | 06-08-2022 |
$23.04 | $23.785 | $23.04 | $23.785 | $23.04 | 286 | 06-07-2022 |
$22.77 | $22.77 | $22.77 | $22.77 | $22.77 | 60 | 06-06-2022 |
$23.94 | $23.94 | $23.94 | $23.94 | $23.94 | 184 | 06-02-2022 |
$23.43 | $23.43 | $23.43 | $23.43 | $23.43 | 22 | 06-01-2022 |
$23.52 | $23.52 | $23.52 | $23.52 | $23.52 | 28 | 05-30-2022 |
$23.52 | $23.52 | $23.52 | $23.52 | $23.52 | 28 | 05-27-2022 |
$22.45 | $22.45 | $22.45 | $22.45 | $22.45 | 30 | 05-26-2022 |
$23.415 | $23.415 | $23.415 | $23.415 | $23.415 | 103 | 05-24-2022 |
$23.66 | $23.66 | $23.66 | $23.66 | $23.66 | 33 | 05-23-2022 |
$22.52 | $22.52 | $22.52 | $22.52 | $22.52 | 32 | 05-18-2022 |
$22.9 | $22.9 | $22.9 | $22.9 | $22.9 | 2 | 05-16-2022 |
$23.09 | $23.21 | $23.09 | $23.21 | $23.09 | 80 | 05-13-2022 |
$22.58 | $23.08 | $22.58 | $23.1 | $22.58 | 429 | 05-12-2022 |
$22.13 | $22.13 | $22.13 | $22.13 | $22.13 | 28 | 05-11-2022 |
$21.08 | $21.08 | $21.08 | $21.08 | $21.08 | 55 | 05-10-2022 |
$20.98 | $21.41 | $20.98 | $21.41 | $20.98 | 77 | 05-09-2022 |
$21.95 | $21.95 | $21.95 | $21.95 | $21.95 | 37 | 05-06-2022 |
$21.79 | $21.86 | $21.79 | $21.86 | $21.79 | 108 | 05-05-2022 |
$22.2 | $22.34 | $22.2 | $24.06 | $22.2 | 360 | 05-04-2022 |
News, Short Squeeze, Breakout and More Instantly...
H Lundbeck A/S Company Name:
HLUKF Stock Symbol:
OTCMKTS Market:
COPENHAGEN, Denmark , Aug. 31, 2020 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) today announced headline results from the parallel group, double-blind, randomized, placebo-controlled RELIEF study [i] that assessed the efficacy and tolerability of Vyepti when initiated during a migrain...
Health Canada Approves Otsuka and Lundbeck's REXULTI® (brexpiprazole) as Adjunctive Treatment of Major Depressive Disorder Canada NewsWire MONTREAL, Feb. 22, 2019 MONTREAL , Feb. 22, 2019 /CNW Telbec/ - Otsuka Pharmaceutical Canada Inc. (Otsuka) and Lundbeck Can...